Serum syndecan-1 reflects organ dysfunction in critically ill patients
Abstract Syndecan-1 (SDC-1) is found in the endothelial glycocalyx and shed into the blood during systemic inflammatory conditions. We investigated organ dysfunction associated with changing serum SDC-1 levels for early detection of organ dysfunction in critically ill patients. To evaluate the effec...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/af37f7bf72324037a4a2453605026188 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:af37f7bf72324037a4a2453605026188 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:af37f7bf72324037a4a24536050261882021-12-02T15:27:06ZSerum syndecan-1 reflects organ dysfunction in critically ill patients10.1038/s41598-021-88303-72045-2322https://doaj.org/article/af37f7bf72324037a4a24536050261882021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88303-7https://doaj.org/toc/2045-2322Abstract Syndecan-1 (SDC-1) is found in the endothelial glycocalyx and shed into the blood during systemic inflammatory conditions. We investigated organ dysfunction associated with changing serum SDC-1 levels for early detection of organ dysfunction in critically ill patients. To evaluate the effect of SDC-1 on laboratory parameters measured the day after SDC-1 measurement with consideration for repeated measures, linear mixed effects models were constructed with each parameter as an outcome variable. A total of 94 patients were enrolled, and 831 samples were obtained. Analysis using mixed effects models for repeated measures with adjustment for age and sex showed that serum SDC-1 levels measured the day before significantly affected several outcomes, including aspartate aminotransferase (AST), alanine transaminase (ALT), creatinine (CRE), blood urea nitrogen (BUN), antithrombin III, fibrin degradation products, and D-dimer. Moreover, serum SDC-1 levels of the prior day significantly modified the effect between time and several outcomes, including AST, ALT, CRE, and BUN. Additionally, increasing serum SDC-1 level was a significant risk factor for mortality. Serum SDC-1 may be a useful biomarker for daily monitoring to detect early signs of kidney, liver and coagulation system dysfunction, and may be an important risk factor for mortality in critically ill patients.Keiko SuzukiHideshi OkadaKazuyuki SumiHiroyuki TomitaRyo KobayashiTakuma IshiharaYoshinori KakinoKodai SuzukiNaomasa YoshiyamaRyu YasudaYuichiro KitagawaTetsuya FukutaTakahito MiyakeHaruka OkamotoTomoaki DoiTakahiro YoshidaShozo YoshidaShinji OguraAkio SuzukiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Keiko Suzuki Hideshi Okada Kazuyuki Sumi Hiroyuki Tomita Ryo Kobayashi Takuma Ishihara Yoshinori Kakino Kodai Suzuki Naomasa Yoshiyama Ryu Yasuda Yuichiro Kitagawa Tetsuya Fukuta Takahito Miyake Haruka Okamoto Tomoaki Doi Takahiro Yoshida Shozo Yoshida Shinji Ogura Akio Suzuki Serum syndecan-1 reflects organ dysfunction in critically ill patients |
| description |
Abstract Syndecan-1 (SDC-1) is found in the endothelial glycocalyx and shed into the blood during systemic inflammatory conditions. We investigated organ dysfunction associated with changing serum SDC-1 levels for early detection of organ dysfunction in critically ill patients. To evaluate the effect of SDC-1 on laboratory parameters measured the day after SDC-1 measurement with consideration for repeated measures, linear mixed effects models were constructed with each parameter as an outcome variable. A total of 94 patients were enrolled, and 831 samples were obtained. Analysis using mixed effects models for repeated measures with adjustment for age and sex showed that serum SDC-1 levels measured the day before significantly affected several outcomes, including aspartate aminotransferase (AST), alanine transaminase (ALT), creatinine (CRE), blood urea nitrogen (BUN), antithrombin III, fibrin degradation products, and D-dimer. Moreover, serum SDC-1 levels of the prior day significantly modified the effect between time and several outcomes, including AST, ALT, CRE, and BUN. Additionally, increasing serum SDC-1 level was a significant risk factor for mortality. Serum SDC-1 may be a useful biomarker for daily monitoring to detect early signs of kidney, liver and coagulation system dysfunction, and may be an important risk factor for mortality in critically ill patients. |
| format |
article |
| author |
Keiko Suzuki Hideshi Okada Kazuyuki Sumi Hiroyuki Tomita Ryo Kobayashi Takuma Ishihara Yoshinori Kakino Kodai Suzuki Naomasa Yoshiyama Ryu Yasuda Yuichiro Kitagawa Tetsuya Fukuta Takahito Miyake Haruka Okamoto Tomoaki Doi Takahiro Yoshida Shozo Yoshida Shinji Ogura Akio Suzuki |
| author_facet |
Keiko Suzuki Hideshi Okada Kazuyuki Sumi Hiroyuki Tomita Ryo Kobayashi Takuma Ishihara Yoshinori Kakino Kodai Suzuki Naomasa Yoshiyama Ryu Yasuda Yuichiro Kitagawa Tetsuya Fukuta Takahito Miyake Haruka Okamoto Tomoaki Doi Takahiro Yoshida Shozo Yoshida Shinji Ogura Akio Suzuki |
| author_sort |
Keiko Suzuki |
| title |
Serum syndecan-1 reflects organ dysfunction in critically ill patients |
| title_short |
Serum syndecan-1 reflects organ dysfunction in critically ill patients |
| title_full |
Serum syndecan-1 reflects organ dysfunction in critically ill patients |
| title_fullStr |
Serum syndecan-1 reflects organ dysfunction in critically ill patients |
| title_full_unstemmed |
Serum syndecan-1 reflects organ dysfunction in critically ill patients |
| title_sort |
serum syndecan-1 reflects organ dysfunction in critically ill patients |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/af37f7bf72324037a4a2453605026188 |
| work_keys_str_mv |
AT keikosuzuki serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT hideshiokada serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT kazuyukisumi serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT hiroyukitomita serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT ryokobayashi serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT takumaishihara serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT yoshinorikakino serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT kodaisuzuki serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT naomasayoshiyama serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT ryuyasuda serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT yuichirokitagawa serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT tetsuyafukuta serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT takahitomiyake serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT harukaokamoto serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT tomoakidoi serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT takahiroyoshida serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT shozoyoshida serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT shinjiogura serumsyndecan1reflectsorgandysfunctionincriticallyillpatients AT akiosuzuki serumsyndecan1reflectsorgandysfunctionincriticallyillpatients |
| _version_ |
1718387223292805120 |